Moberg Pharma AB (publ) (MBGPF)

Moberg Pharma AB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	58	52	43	42	22	26
Market Cap Growth	44.02%	22.05%	1.53%	93.23%	-16.39%	50.10%
Enterprise Value	34	27	15	33	8	14
Last Close Price	1.00	1.05	0.86	-	-	-
PE Ratio	-	-	-	-	-	31.57
PS Ratio	39.44	35.66	48.40	-	1101.38	-
PB Ratio	0.80	0.73	0.69	0.70	0.43	0.55
P/TBV Ratio	0.80	0.73	0.69	0.70	0.43	0.55
EV/Sales Ratio	23.23	18.43	17.28	-	421.77	-
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.01
Net Debt / Equity Ratio	-0.34	-0.34	-0.42	-0.09	-0.22	-0.23
Net Debt / EBITDA Ratio	8.58	8.58	0.89	2.07	6.09	5.00
Net Debt / FCF Ratio	13.06	13.06	17.56	1.68	7.09	6.45
Asset Turnover	0.02	0.02	0.02	-	0	-
Inventory Turnover	1.49	1.49	0.61	-	-	-
Quick Ratio	14.49	14.49	17.59	2.99	4.74	6.68
Current Ratio	14.71	14.71	17.95	3.38	4.77	6.74
Return on Equity (ROE)	-4.03%	-4.03%	-39.32%	-3.69%	-3.25%	-3.91%
Return on Assets (ROA)	-2.46%	-2.46%	-30.29%	-2.91%	-2.53%	-2.65%
Return on Invested Capital (ROIC)	-6.21%	-6.55%	-68.21%	-5.76%	-5.47%	-5.49%
Return on Capital Employed (ROCE)	-4.10%	-4.10%	-47.10%	-4.50%	-3.80%	-4.50%
Earnings Yield	-5.10%	-5.64%	-53.72%	-4.96%	-6.89%	3.17%
FCF Yield	-	-3.62%	-3.47%	-7.81%	-7.39%	-6.47%
Buyback Yield / Dilution	-23.78%	-23.78%	-138.46%	-109.19%	-76.28%	-127.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.